Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis
- Author
- JANG, Hyunbum1 ; CONNELLY, Laura2 ; TERAN ARCE, Fernando2 ; RAMACHANDRAN, Srinivasan2 ; LAL, Ratnesh2 ; KAGAN, Bruce L3 ; NUSSINOV, Ruth1 4
[1] Center for Cancer Research, Nanobiology Program, Basic Science Program, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Maryland 21702, United States
[2] Departments of Bioengineering and of Mechanical and Aerospace Engineering, and Materials Science Program, University of California, San Diego, La Jolla, California 92093, United States
[3] Department of Psychiatry, David Geffen School of Medicine, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California 90024, United States
[4] Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel - Source
PCCP. Physical chemistry chemical physics (Print). 2013, Vol 15, Num 23, pp 8868-8877, 10 p ; ref : 104 ref
- Publisher
- Royal Society of Chemistry, Cambridge
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Article synthèse Hydrophobicité Ion Lipide Médicament Oligomère Peptide Précurseur Structure
- Keyword (en)
- Review Hydrophobicity Ions Lipids Drug Oligomer Peptides Precursor Structure
- Keyword (es)
- Artículo síntesis Hidrofobicidad Ión Lípido Medicamento Oligómero Péptido Precursor Estructura
- Classification
- Discipline
- Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27423269
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1039/c3cp00017f 
https://dx.doi.org/10.1039/c3cp00017f
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1039\/c3cp00017f\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:9:\"\u0000*\u0000jtitle\";s:49:\"PCCP. Physical chemistry chemical physics (Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"PCCP, Phys. chem. chem. phys. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"23\";s:8:\"\u0000*\u0000spage\";s:4:\"8868\";s:8:\"\u0000*\u0000epage\";s:4:\"8877\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1463-9076\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"JANG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Hyunbum\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"CONNELLY, Laura\";i:1;s:20:\"TERAN ARCE, Fernando\";i:2;s:24:\"RAMACHANDRAN, Srinivasan\";i:3;s:12:\"LAL, Ratnesh\";i:4;s:14:\"KAGAN, Bruce L\";i:5;s:14:\"NUSSINOV, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:8:\"\u0000*\u0000place\";s:9:\"Cambridge\";s:6:\"\u0000*\u0000pub\";s:26:\"Royal Society of Chemistry\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1039\/c3cp00017f\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:9:\"\u0000*\u0000jtitle\";s:49:\"PCCP. Physical chemistry chemical physics (Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"PCCP, Phys. chem. chem. phys. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"23\";s:8:\"\u0000*\u0000spage\";s:4:\"8868\";s:8:\"\u0000*\u0000epage\";s:4:\"8877\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1463-9076\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"JANG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Hyunbum\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"CONNELLY, Laura\";i:1;s:20:\"TERAN ARCE, Fernando\";i:2;s:24:\"RAMACHANDRAN, Srinivasan\";i:3;s:12:\"LAL, Ratnesh\";i:4;s:14:\"KAGAN, Bruce L\";i:5;s:14:\"NUSSINOV, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:8:\"\u0000*\u0000place\";s:9:\"Cambridge\";s:6:\"\u0000*\u0000pub\";s:26:\"Royal Society of Chemistry\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1039\/c3cp00017f\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1039\/c3cp00017f\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:9:\"\u0000*\u0000jtitle\";s:49:\"PCCP. Physical chemistry chemical physics (Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"PCCP, Phys. chem. chem. phys. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"23\";s:8:\"\u0000*\u0000spage\";s:4:\"8868\";s:8:\"\u0000*\u0000epage\";s:4:\"8877\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1463-9076\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"JANG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Hyunbum\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"CONNELLY, Laura\";i:1;s:20:\"TERAN ARCE, Fernando\";i:2;s:24:\"RAMACHANDRAN, Srinivasan\";i:3;s:12:\"LAL, Ratnesh\";i:4;s:14:\"KAGAN, Bruce L\";i:5;s:14:\"NUSSINOV, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:8:\"\u0000*\u0000place\";s:9:\"Cambridge\";s:6:\"\u0000*\u0000pub\";s:26:\"Royal Society of Chemistry\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1039\/c3cp00017f\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:9:\"\u0000*\u0000jtitle\";s:49:\"PCCP. Physical chemistry chemical physics (Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"PCCP, Phys. chem. chem. phys. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"23\";s:8:\"\u0000*\u0000spage\";s:4:\"8868\";s:8:\"\u0000*\u0000epage\";s:4:\"8877\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1463-9076\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"JANG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Hyunbum\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"CONNELLY, Laura\";i:1;s:20:\"TERAN ARCE, Fernando\";i:2;s:24:\"RAMACHANDRAN, Srinivasan\";i:3;s:12:\"LAL, Ratnesh\";i:4;s:14:\"KAGAN, Bruce L\";i:5;s:14:\"NUSSINOV, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:8:\"\u0000*\u0000place\";s:9:\"Cambridge\";s:6:\"\u0000*\u0000pub\";s:26:\"Royal Society of Chemistry\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1039\/c3cp00017f\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:9:\"\u0000*\u0000jtitle\";s:49:\"PCCP. Physical chemistry chemical physics (Print)\";s:9:\"\u0000*\u0000stitle\";s:37:\"PCCP, Phys. chem. chem. phys. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"23\";s:8:\"\u0000*\u0000spage\";s:4:\"8868\";s:8:\"\u0000*\u0000epage\";s:4:\"8877\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1463-9076\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"JANG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Hyunbum\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"CONNELLY, Laura\";i:1;s:20:\"TERAN ARCE, Fernando\";i:2;s:24:\"RAMACHANDRAN, Srinivasan\";i:3;s:12:\"LAL, Ratnesh\";i:4;s:14:\"KAGAN, Bruce L\";i:5;s:14:\"NUSSINOV, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Alzheimer's disease: which type of amyloid-preventing drug agents to employ? : Insights into protein misfolding and amyloidogenesis\";s:8:\"\u0000*\u0000place\";s:9:\"Cambridge\";s:6:\"\u0000*\u0000pub\";s:26:\"Royal Society of Chemistry\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
